Intramuscular 30% polymethylmethacrylate (PMMA) implants in a non-protein vehicle: an experimental study in rats

• Autor(a) principal: Puricelli,Edela
• Data de Publicação: 2011
• Outros Autores: Nácul,Almir Moojen, Ponzoni,Deise, Corsetti,Adriana, Hildebrand,Laura de Campos, Valente,Denis Souto
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista Brasileira de Cirurgia Plástica (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1983-51752011000300004
• topic: Biocompatible materials; Polymethyl methacrylate; Masseter muscle

INTRODUCTION: In the present study, the stability and biocompatibility of a 30% polymethylmethacrylate (PMMA) filling material implanted in the masseter muscle of rats were investigated according to the cytologic characteristics presented in the graft versus host reaction. METHODS: The study included 20 rats, which were divided into 4 groups: groups I, II, III, and IV corresponded to animals evaluated 7, 14, 45, and 60 days after surgery, respectively. The implant was placed in the right masseter muscle at the level of the mandibular angle. RESULTS: After 7 days, lymphoplasmacytic inflammatory infiltrates, a fibrous capsule, a large number of neutrophils, macrophages, and exudate were observed. The second group (14 days) showed granulation tissue composed of a lymphoplasmacytic inflammatory infiltrate, newly formed vessels, and a fibrous capsule. However, the second group also exhibited regeneration of the muscle fibers, and a decreased number of neutrophils and exudate. After 45 and 60 days, the inflammatory infiltrate decreased in intensity compared to the first 2 groups. CONCLUSIONS: The inflammatory reaction caused by PMMA is transient and does not compromise the function and the shape of the masseter muscle tissue, suggesting that PMMA is biocompatible.